Clinical trial
Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Stents in Patients With Chronic Total Occlusion
NCT02739685 is registered in ClinicalTrials.gov with University of Luebeck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Stents in Patients With Chronic Total Occlusion
- Lead sponsor
- University of Luebeck
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 30, 2016
- Completion date
- January 31, 2017
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.